Marc Wilson

Chief Financial Officer


Marc Wilson joined Crinetics as Chief Financial Officer in January 2018. He previously served as Vice President of Finance and Accounting and Chief Accounting Officer at Cidara Therapeutics, where he led the company through its Series A financing and IPO. Marc has also held roles at Trius Therapeutics, Neurocrine Biosciences, and PricewaterhouseCoopers LLP. He is a certified public accountant and holds a bachelor’s degree in economics and accounting from the College of the Holy Cross.